Havemeyer Place LP Acquires New Shares in Masimo Corporation $MASI

Havemeyer Place LP acquired a new stake in Masimo Corporation (NASDAQ:MASI) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 3,020 shares of the medical equipment provider’s stock, valued at approximately $393,000.

Other hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC purchased a new position in Masimo in the 4th quarter valued at approximately $27,000. Rothschild Investment LLC grew its stake in Masimo by 12,950.0% in the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares in the last quarter. Torren Management LLC purchased a new position in Masimo in the 4th quarter valued at approximately $35,000. Smartleaf Asset Management LLC grew its stake in Masimo by 80.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 136 shares in the last quarter. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in Masimo in the 4th quarter valued at approximately $44,000. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Stock Up 0.0%

Shares of NASDAQ:MASI opened at $179.95 on Wednesday. The firm has a fifty day moving average price of $178.56 and a two-hundred day moving average price of $159.94. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. Masimo Corporation has a one year low of $125.94 and a one year high of $179.99. The company has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11.

Wall Street Analyst Weigh In

MASI has been the subject of a number of recent research reports. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a research note on Tuesday, February 17th. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Nine analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.